Search
Collegium Pharmaceutical Inc
COLLAdd to Watchlist
27.110USD
-0.430-1.56%
Close 08-21 16:00（ET）
881.19MMarket Cap
11.49P/E TTM
Forecast
Currency: USD Updated: 2026-08-20The current earnings forecast score of Collegium Pharmaceutical Inc is 8.00, ranking 59 out of 158 in the Pharmaceuticals industry. The average price target is 48.00, with a high of 58.00 and a low of 44.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
51.000
Target Price
+78.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Collegium Pharmaceutical Inc
COLL
6
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Regeneron Pharmaceuticals Inc
REGN
30
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Collegium Pharmaceutical Inc's expected revenue for the next quarter?
Collegium Pharmaceutical Inc's expected revenue is 218.47M.
What is Collegium Pharmaceutical Inc's price target?
Analysts forecast that Collegium Pharmaceutical Inc's price target is USD 48.00, with the highest forecast at USD 58.00 and the lowest forecast at USD 44.00.
How have Collegium Pharmaceutical IncCOLL's recent earnings per share performed?
The market expectation was USD -0.46, while Collegium Pharmaceutical IncCOLL's earnings per share (EPS) for the previous quarter was USD 0.45. EPS for the next quarter is expected at USD 1.86.
What is the analyst rating for Collegium Pharmaceutical Inc?
Based on the ratings of Collegium Pharmaceutical Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.